ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Dowex 50W: Mild Efficient Reusable Heterogeneous Catalyst for Synthesis of Quinoxaline Derivatives in Aqueous Medium

Arup Datta1 and Samiran Halder2*

1Department of Chemistry, Shibpur Dinobundhoo Institution (College), 412/1 G.T Road (South), Shibpur, Howrah, India.

2Department of Chemistry, Charuchandra College, 22, Lake Road, Kolkata-700029, India.

Corresponding Author E-mail: samiran14cd@gmail.com

DOI : http://dx.doi.org/10.13005/ojc/360629

Article Publishing History
Article Received on : 21-09-2020
Article Accepted on :
Article Published : 06 Nov 2020
Article Metrics
ABSTRACT:

An efficient, simple and eco-friendly procedure is reported in presence of heterogeneous Dowex 50W catalyst in aqueous medium under refluxing condition to produce quinoxaline derivatives. Catalyst has participated in condensation reaction between 1,2-diamines and various aromatic 1,2-diketones smoothly with excellent yield of the products in short reaction times. Dowex 50W was used more than five times in this reaction separately and showed an excellent recyclability throughout the reaction.

KEYWORDS:

Aqueous Medium; Diamines; Dowex 50W; Heterogeneous Catalyst; Quinoxaline Derivatives

Download this article as: 

Copy the following to cite this article:

Datta A, Halder S. Dowex 50W: Mild Efficient Reusable Heterogeneous Catalyst for Synthesis of Quinoxaline Derivatives in Aqueous Medium. Orient J Chem 2020;36(6).


Copy the following to cite this URL:

Datta A, Halder S. Dowex 50W: Mild Efficient Reusable Heterogeneous Catalyst for Synthesis of Quinoxaline Derivatives in Aqueous Medium. Orient J Chem 2020;36(6). Available from: https://bit.ly/3eI0B5D


Introduction

In past few years,the quinoxaline derivatives get immense interest in medicinal chemistry as useful intermediates.1,2 Six membered 1,4-nitrogens containing heterocycles quinoxaline has tremendous biological activity and employed in the following diseases such as antibacterial,3a anti-protozoal,3b anti-inflammatory,3c anti-viral,3d  anti-cancer,3e antidepressant,3f kinase inhibitors3g,h and as anti-HIV.3j In an agricultural field, these derivatives are used extensively as herbicides, fungicides and insecticides.4 Dye preparation,5 preparation of the organic semi conductors,6 manufacture of electronic substances,7 chemically controllable switch preparation,8 anion receptor for the formation of building block9 are the valuable another practical aspects of this derivatives are reported. Different antibiotics like levomycin, echinomycin and actinoleutin where the quinoxaline derivatives present as a core moiety. It inhibits the development of gram positive bacteria and used against different transplantable tumors.10

Various methods are available for the formation of these derivatives. The conventional protocol is the condensation between ortho-phenylenediamine and 1,2- dicabonyl system under refluxing methanol in AcOH.11 Later, many advanced methodology were found to synthesize these derivatives using oxidative coupling with two different catalyst at a time,12 in solid phase synthesis13 and microwave irradiation.14 The following catalysts MnO2,15 zeolites,16 CAN,17 MontmorilloniteK-10,18 ionic liquid,19 SiO2 H2SO4,20 Nickel-nanoparticles,21 gallium(III)triflate,22 Pd(OAc)2,23 Al2O3,24 were used to prepare these derivatives. Other methods are also helpful like coupling between an epoxides and o-phenylenediamines followed by oxidation.25 Reaction between aromatic amino oximes and 1,2-dicarbonyl compounds26 and oxidation of α-hydroxyl ketones known as a tandem method27 is used to design these derivatives. Acetonitrile,28 and other organic solvents were continuously used to generate a good yield of the products because of their greater solvation properties of organic substrates. Recently, some methods were reported for the development of the derivatives using catalysts such as AcOH at 130 oC and DMSO.29 Beside this, solvent free technique was applied to generate a good yield of the quinoxaline derivatives. Not only ultrasound,30 microwave irradiation24,31 and room temperature32 processes were also applied to prepare the quinoxaline derivatives with good yields.

Solid acid catalyst in organic transformation always plays a vital role rather than hazardous inorganic catalyst. Safe and simplicity of the process, minimized plant corrosion and environmentally benign waste disposal procedures are main advantages associated with solid heterogeneous acid catalyst.33 Researchers are constantly searching to develop such type of green catalyst that can be replaced inorganic acid easily in methodological reaction to develop a good yield of the product.

Results and Discussions

Dowex 50W is an environmentally friendly and cheap catalyst has been receiving striking importance in synthetic organic chemistry.34a It is a cation exchange sulphonic acid based resin produces H+ ion in aqueous medium easily. This catalyst was used previously in aqueous medium to synthesize 2-aryl-1H-benzimidazole34b and 2-substituted benzothiazole derivatives with excellent yields in a short reaction time.34c

Initially, we had started first the reaction between o-phenylenediamines 1a with benzil 2a for the synthesis of 2,3-diphenylquinoxaline (3a, Scheme 1) under different refluxing conditions to investigate the catalyst loading and solvent effect.

 

Scheme 1: Synthesis of quinoxaline derivatives by Dowex 50W in H2O

Click here to View Scheme

Our target was to design this synthesis in environmentally friendly condition and for this purpose we applied water as a solvent in this reaction. Water always acts as an environmentally benign solvent because it possesses the following advantages; such as nonflammable, readily available in huge quantities, no carcinogenic effect and very secure to operate.34a So, to investigate a new synthetic green methodology, wehavereported an effective and simplest condensation method between 1,2-dicarbonyl compound and ortho-phenylenediamine in presence of  heterogeneous catalyst Dowex 50W under refluxing condition to prepare quinoxaline derivatives. In order to investigate the reaction conditions such as mol % of the catalyst and choice of solvent with respect to % yields, we have used benzil (1 mmol) and ortho-phenylenediamine (1.2 mmol) as substrates in different conditions.

Table 1: Effect of catalyst and solvent for the formation of quinoxaline derivatives

Entry

Dowex 50W (mol%)

aConditions

Solvent

(5 mL)

Time (min)

bYield  (%)

1

NIL

Oil bath, Reflux

water

110

0

2

5

Oil bath, Reflux

water

110

30

3

10

Oil bath, Reflux

water

110

88

4

15

Oil bath, Reflux

water

110

88

6

20

Oil bath, Reflux

water

110

90

7

25

Oil bath, Reflux

water

110

88

8

30

Oil bath, Reflux

water

110

88

9

10

Oil bath, Reflux

EtOH

110

65

10

10

Oil bath, Reflux

Aqueous EtOH (1:1)

110

75

11

10

Oil bath, Reflux

MeCN

110

55

12

10

Oil bath, 100 oC

DMSO

110

58

13

10

Oil bath, 100 oC

THF

110

56

14

10

Oil bath, 100 oC

NIL

110

40

aReaction conditions: o-phenylenediamine (1.2 mmol), Benzil (1 mmol), bIsolated yield

A non catalytic reaction was performed first between ortho-phenylenediamine and benzil in water under refluxing condition for 110 minutes no quinoxaline derivative was observed by TLC experiment, so acid catalyst was essential to generate the quinoxaline derivatives (Entry 1, Table 1). Step by step increasing mol% of the catalyst, increases the % yield of the products gradually and to complete the reaction 10 mol% of the catalyst was required under this reaction conditions that has been proved previous published papers.34 More than 10 mol % of the catalyst that means 20 and 30 mol% of the catalyst was not related to improve the product. Thereafter we have examined the reaction in presence of polar protic and aprotic solvents separately. Without solvent, poor yield of quinoxaline derivative was detected (Entry 14, Table 1). Almost, all the solvents gave moderate yields except water, which afforded 88% yield (Entry 3, Table 1). Even if 1:1 aqueous alcoholic solvent is employed, the yield was only 75% (Entry 10, Table 1). So, by combining the effect of catalyst and solvent, we can conclude that Dowex 50W catalyst in 10 mol% was appropriate in aqueous medium to generate an excellent yield of the quinoxaline derivatives.

With this initial result, we have studied the catalytic system Dowex 50W in water at refluxing condition with various o-aromaticdiamines 1 and 1,2-diketones 2 forming the desired substituted quinoxaline 3  derivatives and the outcome were depicted in Table 2. Electron pushing and pulling both group attached in aromatic ring of 1,2-diketones were investigated. Various electron donating and withdrawing groups attached to o-aromaticdiamines also examined. All the cases low reaction times and excellent yield of the products was observed.

Electron-pushing group at the aromatic ring of o-diamine favoured the development of products (Entries 8 and 9, Table 2) to provide better yields. Electron-pulling groups in contrast such as bromo, chloro and benzoyl afforded the desired products in slightly lower yields (80-84%) (Entries10-12, Table 2). The reaction of aliphatic 1,2-diammine 1f with 1,2-diphenyldiketone 2a was also examined and obtained a moderate yield (78%) of the desired product 3 even after running the reaction under refluxing condition for 3 hours (Entry 15, Table 2). Reaction of 2,3-diaminonaphthalene 1g  and 1,2-diphenyldiketone 2a  also gave a low yield compared to others. In contrast, no significant change of product yield was observed when substituents present at the 1,2-diketones.

Table 2: Synthesis of quinoxaline derivative

Click here to View table

In summary, quinoxaline derivatives have been created in presence of promoter Dowex 50W in aqueous medium. This method has several advantages such as a very mild reaction conditions, short reaction times, easy workup and high yield of the products. Here Dowex 50W acts as a reusable green catalyst because it can be easily separated from the reaction medium and reused for several reactions with no alteration of catalytic activity. For the production of quinoxaline derivatives in large-scale this method will be helpful in near future.

The plausible mechanistic pathway is depicted in Scheme 2 to generate quinoxalines using 1,2-diketones and o-diamines. Since Dowex 50W is a proton source in aqueous medium so in the first step protonation takes place at the carbonyl oxygen atom which makes more electrophilicity of the o-phenylenediamines 1a and then quinoxaline derivatives 3a were generated by the elimination of twice water molecules and detailsshown in the mechanism.

Scheme 2: Plausible mechanism for the production of quinoxaline derivatives

Click here to View Scheme

Experimental

Chemicals o-aromaticdiamine (1), 1,2-diketones (2) and Dowex 50W in acid form were purchased from Spectrochem Pvt. Ltd. (Mumbai, India) and SRL, India. 1H-NMR and 13C-NMR spectra were recorded on a Bruker 300 MHz spectrometer. From Aldrich chemical company NMR solvents CDCl3, DMSO-d6 and TMS as the internal standard were purchased. Perkin Elmer Spectrophotometer was used to study FT-IR spectra. Thin layer chromatography was used to monitor the reaction. Electrical melting point apparatus were used to determine the melting point.

General Procedure

1,2-diketones (1.0 mmol), o-aromaticdiamines (1.2 mmol), 5 mL water and Dowex 50W (10 mol%) were taken in a 50 mL Erlenmeyer flask with a condenser and it was refluxed in an oil bath with a specific time period with stirring. The reaction was monitored by TLC time to time. After the complete conversion of the reaction indicated by brown spot in TLC then the crude product was cooled and diluted with 5 mL ethanol and Dowex 50W was separated by filtration.  Solution was concentrated and it was kept in the refrigerator for crystallization to prepare pure crystals of quinoxaline derivatives. 1H-NMR, 13C-NMR and FT-IR spectral data of all the known compounds (3a-n) were checked with the data of authentic known compounds.

Selected characterization data for synthesized compounds

2,3-Diphenylquinoxaline (3a)

White solid, M.P: 127 oC [Lit.35 128-129 ºC],FT-IR (neat, cm-1): 3056, 1541, 1495, 1449, 1356,1H NMR (300 MHz, CDCl3): d: 7.32-7.37 (m, 6H), 7.56 (dd, 4H), 7.75 (dd, 2H), 8.2 (dd,  2H), 13CNMR (75MHz, CDCl3): d: 153.5, 141.3, 139.2, 129.9, 129.8, 129.3, 128.8, 128.3 , Analytical calculation for C20H14N2(%): C: 85.08; H: 5.00; N: 9.92; Found: C: 85.00; H: 4.90; N: 9.82.

4-(2-(4-Chlorophenyl)quinoxalin-3-yl)-N,N-dimethylbenzenamine (3e)

White solid, M.P: 170 oC. [Lit.37 168-170 ºC],FT-IR (neat, cm-1): 3057, 2932, 1616, 1542, 1449, 1354,1H NMR (300 MHz, CDCl3): d: 3.01 (s, 2Me, 6H), 6.68 (dd, 2H), 7.37 (dd, 2H), 7.45 (dd, 2H), 7.57 (dd, 2H), 7.70-7.75 (m, 2H), 8.11-8.14 (m, 2H),13CNMR (75MHz, CDCl3): d: 153.3, 152.2, 150.9, 141.6, 140.6, 138.6, 134.8, 131.1, 131.0, 129.9, 129.2, 129.1, 129.0, 128.6, 126.0, 111.8, 40.0, Analytical calculation for C22H18ClN3 (%): C: 73.43; H: 5.04; N: 11.68; Found: C: 73.33; H: 4.89; N: 11.43.  

6-Chloro-2,3-diphenylquinoxaline (3k)

White solid, M.P: 125 oC. [Lit.35 124-125 ºC],FT-IR (neat, cm-1): 3056, 1606,  1498,1H NMR (300 MHz, CDCl3): d: 8.19 (s, 1H), 8.14 (d, 1H), 7.74 (m, 1H), 7.53 (d, 4H), 7.40 (m, 6H),13C NMR (75MHz, CDCl3): d: 154.5, 153.7, 141.4, 139.7, 138.9, 135.7, 132.2, 131.0, 130.5, 130.0, 129.9, 129.8, 129.2, 129.1, 128.8, 128.1, Analytical calculation for C20H13ClN2 (%): C: 75.83; H: 4.14; N: 8.84; Found: C: 75.83; H: 4.14; N: 8.84.

Conclusion 

New high yielding Eco-friendly protocol has been developed for preparing various substituted quinoxaline derivatives using easily available, nontoxic and nonhazardous heterogeneous catalyst Dowex 50W in aqueous medium. A series of quinoxaline derivatives were synthesized with various 1,2-diketones and different o-phenylenediamine under mild and green reaction condition with excellent yield. Green solvent, simple methodology and easy purification of wide variety of the isolated products are the main advantages of our process.

Acknowledgement

AD is very much grateful to his Ph.D. supervisor Prof. Chhanda Mukhopadhyay, Dept. of Chemistry, University of Calcutta for providing laboratory facility. Authors are thankful to the staff of the Dept. of Chemistry for their continuous support.

Conflict of Interest

No conflict of interest regarding this article  

References

  1. Katritzky, A. R.; Rees, C.W.; Comprehensive Heterocyclic Chemistry, Pergamon: Oxford, Part 2B., 1984,  3, 157.
    CrossRef
  2. Sherman, D.; Kawakami, J.; He, H. Y.; Dhun, F.; Rios, R.; Liu, H.; Pan, W.; Xu, Y. J.;Hong, S. P.; Arbour, M.; Labelle M.; Duncton, M. A. J.; Tetrahedron Lett., 2007, 48, 8943.
    CrossRef
  3. (a) Seitz, L. E.; Suling, W. J.; Reynolds, R. C.; J. Med. Chem., 2002, 45, 5604-5606. (b) Hui, X.; Desrivot, J.; Bories, C.; Loiseau, P. M.; Franck, X.; Hocquemiller, R.; Figadere, B.; Bioorg. Med. Chem. Lett., 2006, 16, 815-820. (c) YB, K.; YH, K.; JY, P.; SK, K.; Bioorg. Med. Chem. Lett., 2004, 14, 541-544. (d) Loriga, M.; Piras, S.; Sanna, P.; Paglietti, G. Farmaco., 1997, 52, 157-166. (e) Lindsley, C. W.; Zhao, Z.; Leister, W. H.; Robinson, R. G.; Barnett, S. F.; Defeo-Jones, D.; Jones, R. E.; Hartman, G. D.; Huff, J. R.; Huber, H. E.; Duggan, M. E.; Bioorg. Med. Chem. Lett., 2005, 15, 761-764. (f) Sarges, R.; Howard, H. R.; Browne, R. G.; Lebel, L. A.; Seymour, P. A.; Koe, B. K.; J. Med. Chem. 1990, 33, 2240-2254. (g) Srinivas, C.; Kumar, C. N. S. S. P.; Rao, V. J.; Palaniappan, S.; J. Mol. Catal. A: Chem., 2007, 265, 227-230. (h) Ghomsi, N. T.; Ahabchane, N. E. H.; Es-Safi, N. E.; Garrigues, B.; Essassi, E. M.; Spectroscopy Lett., 2007, 40, 741-751. (j) Hui, X.; Desrivot, J.; Bories, C.; Loiseau, P. M.; Franck, X.; Hocquemiller, R.; Figadere, B.; Bioorg. Med. Chem. Lett., 2006, 16, 815.
    CrossRef
  4. Sakata, G.; Makino, K.; Karasawa, Y.; Heterocycles., 1988, 27, 2481-2515.
    CrossRef
  5. (a) Kumar, A.; Kumar, S.; Saxena, A.; De, A.; Mozumdar, S.; Catal. Commun., 2008, 9, 778-784. (b) Jaung, J. Y.; Dyes and Pigments., 2006, 71, 45.
    CrossRef
  6. Dailey, S.; Feast, W. J.; Peace, R. J.; Sage, I. C.; Till, S.; Wood, E L.; J. Mater. Chem., 2001, 11, 2238-2243.
    CrossRef
  7. Thomas, K. R. J.; Velusamy, M.; Lin, J. T.; Chuen, C. H.; Tao, Y. T.; Chem. Mater., 2005, 17, 1860-1866.
    CrossRef
  8. Crossley, M. J.; Johnston, L. A.; Chem. Commun., 2002, 1122.
    CrossRef
  9. Kazunobu, T.; Ryusuke, O.; Tomohiro, M.; Chem. Commun., 2002, 212-219.
  10. (a) Dell, A.; William, D. H.; Morris, H. R.; Smith, G. A.; Feeney, J.; Roberts, G. C. K.; J. Am. Chem. Soc., 1975, 97, 2497-2502. (b) Heravi, M. M.; Bakhtiari, K.; Tehrani, M. H.; Javadi, N. M.; Oskooie, H. A.; Arkivoc., 2006, (xvi), 16-22. (c) Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K.; Chem. Commun., 2003, 18, 2286.
    CrossRef
  11. (a) Woo, G. H. C.; Snyder, J. K.; Wan, Z. K.; Prog. Heterocycl.Chem., 2002, 14, 279. (b) Roy, P.; Ghorai, B. K.; Beilstein. J. Org. Chem.; 2010, 6, 52.
    CrossRef
  12. Antoniotti, S.; Donach, E.; Tetrahedron Lett., 2002, 43, 3971-3973.
    CrossRef
  13. Wu, Z.; Ede, N. J.; Tetrahedron Lett., 2001, 42, 8115-8118.
    CrossRef
  14. (a) Zhao, Z.; Wisnoski, D. D.; Wolkenberg, S. E.; Leister, W. H.;Wang, Y.; Lindsley, C. W.; Tetrahedron Lett., 2004, 45, 4873-4876. (b) Gris, J.; Glisoni, R.; Fabian, L.; Fernández, B.; Moglioni,A. G.; Tetrahedron Lett., 2008, 49, 1053-1056. (c) Mohsenzadeh, F.; Aghapoor, K.; Darabi, H. R.; J. Braz. Chem. Soc., 2007, 18, 297.
    CrossRef
  15. Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K.; Org. Biomol. Chem., 2004, 2, 788-796.
    CrossRef
  16. Bhosale, R. S.; Sarda, S. R.; Ardhapure, S. S.; Jadhav, W. N.; Bhusare, S. R.; Pawar, R. P.; Tetrahedron Lett., 2005, 46, 7183-7186.
    CrossRef
  17. More, S. V.; Sastry, M. N. V.; Yao, C. F.; Green Chem., 2006, 8, 91-95.
    CrossRef
  18. Huang, T. K.; Wang, R.; Shi, L.; Lu, X. X.; Catal. Commun., 2008, 9, 1143-1147.
    CrossRef
  19. (a) Fang, D.; Gong, K.; Fei, Z.; Zhou, X.; Liu, Z.; Catal. Commun., 2008, 9, 317-320. (b) Potewar, T. M.; Ingale, S. A.; Srinivasan, K. V.; Synth. Commun., 2008, 38, 3601.
    CrossRef
  20. Shaabani, A.; Maleki, A.; Chin. J. Chem., 2007, 25, 818-821.
    CrossRef
  21. Kumar, A.; Kumar, S.; Saxena, A.; De, A.; Mozumdar, S.; Catal. Commun., 2008, 9, 778-784.
    CrossRef
  22. Cai, J. J.; Zou, J. P.; Pan, X. Q.; Zhang, W.; Tetrahedron Lett., 2008, 49, 7386-7390.
    CrossRef
  23. Brown, D. J.; Taylor, E. C.; Wipf, P.; “Quinoxalines,” in The Chemistry of Heterocyclic Compounds: John Wiley & Sons, Hoboken, N. J. USA., Eds., 2004, 61, 1-510.
    CrossRef
  24. Jafarpour, M.; Rezaeifard, A.; Danehchin, M.; Applied Catalysis A: General., 2011, 394, 48-51.
    CrossRef
  25. Antoniotti, S.; Dunach, E.; Tetrahedron Lett., 2002, 43,3971-3973.
    CrossRef
  26. Xekoukoulotakis, N. P.; Hadjiantoniou-Maroulis, C. P.; Maroulis, A. J. Tetrahedron Lett., 2000, 41,10299-10302.
    CrossRef
  27. Raw, S. A.; Wilfred, C. D.; Taylor, R. J. K.; Org. Biomol. Chem., 2004, 2, 788-796.
    CrossRef
  28. More, S. V.; Sastry, M. N. V.; Wang, C. C.; Ching-Fa, Y.; Tetrahedron Lett., 2005, 46, 6345-6348.
    CrossRef
  29. Xie, C.; Zhang, Z.; Li, D.; Gong, J.; Han, X.; Liu, X.; Ma , C.; J. Org. Chem.,2017, 82, 3491-3499.
    CrossRef
  30. Sadjadi, S.; Sadjadi, S.; Hekmatshoar, R.; Ultrason Sonochem., 2010. 17, 764-767.
    CrossRef
  31. Zhou, J. F.; Gong, G. X.; Shi, K. B.; Zhi, S.; J. Chinese Chem. Lett., 2009, 20, 672-675.
    CrossRef
  32. (a) Krishnakumar, B.; Velmurugan, R.; Jothivel, S.; Swaminathan, M.; Catal. Commun., 2010, 11, 997-1002. (b) Darabi, H. R.; Mohandessi, S.; Aghapoor, K.; Mohsenzadeh, F.; Catal. Commun., 2007, 8, 389-392.
    CrossRef
  33. Niknam, K.; Saberi, D.; Mohagheghnejad, M.; Molecules., 2009, 14, 1915-1926.
    CrossRef
  34. (a) Mukhopadhyay, C.; Datta, A.; Banik, B. K.; Heterocycles., 2007, 71, 181-188. (b) Mukhopadhyay, C.; Tapaswi, P. K.; Tetrahedron Lett., 2008, 49, 6237-6240. (c) Makhopadhyay, C.; Datta, A.; J. Het. Chem., 2009, 46, 91-95.
    CrossRef
  35. (a) Steven, A. R.; Cecilia, D. W.; Richard, J. K. T.; Chem. Commun., 2003, 2286. (b) Bhosale, R. S.; Sarda, S. R.; Ardhapure, S. S.; Jadhav, W. N.; Bhusare, S. R.; Pawar, R. P.; Tetrahedron Lett., 2005, 46, 7183-7186. (c) More, S. V.; Sastry, M. N. V.; Wang, C. C.; Yao, C. F.; Tetrahedron Lett., 2005, 46, 6345-6348.
    CrossRef
  36. Mao, L.; Sakurai, H.; Hirao, T.; Synthesis., 2004, 2535-2539.
    CrossRef
  37. Islami, M. R.; Hassani, Z.; Arkivoc., 2008, (xv), 280-287.
    CrossRef
  38. Akkilagunta, V. K.; Reddy, V.P.; Kakulapati, R. R.; Synlett., 2010, 2571-2574.
    CrossRef


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

About The Author